Реклама и продвижение лекарственных средств и медицинских изделий
Ведущие специалисты юридической фирмы GRATA International в рамках отрасли “Фармацевтика и здравоохранение” подготовили материал на тему “Реклама и продвижение лекарственных средств и медицинских изделий” в странах: Беларусь, Грузия, Казахстан, Молдова, Монголия и Узбекистан.
19.02.2021
This is to inform you that on 19 December 2020, the Law of the Republic of Kazakhstan ‘On the Introduction of the Amendments to Some Legislative Acts of the Republic of Kazakhstan on outstaffing services’ (hereinafter – the ‘Law’). Pursuant to the Law, the Labour Code of the Republic of Kazakhstan
Naphtyzinum: ‘Soviet’ Trademark or Public Interest?
In Kazakhstan’s judicial practice there are growing disputes related to the early termination of legal protection for trademarks that have come into common use for the designation of goods of a certain type by virtue of Article 6.1.1 of the Law of the Republic of Kazakhstan 'On Trademarks, Service Marks and Appellations of Origin of Goods' No. 456-I, dated 26 June 1999 (hereinafter - the 'Trademark Law').
News in the Medicines Price Regulations and Medicines Advertising Rules
As outlined in our earlier Overview of main developments in pharmaceuticals regulations of Kazakhstan in 2019, as a result of steady dynamic of medicines prices, we observe the same dynamic in continuous changes of legislative framework governing the pricing of medicines.
The Government of the Kyrgyz Republic has taken measures to provide the population with medicines and medical devices in connection with the pandemic of coronavirus infection
Aidar Oruzbaev, lawyer of Bishkek office of Grata International leading pharmaceutical law practice in the Kyrgyz Republic breaks down the main features of newly adopted Decree of the Kyrgyz Government on measures concerning prevention of further spread of COVID-19.
Legal review of the main
developments in the
pharmaceuticals regulations
of Kazakhstan
The new rules for regulating the prices of medicines ('Price Regulation Rules 2019') were adopted in April 2019. Over the past five years, this is the third regulatory legal act establishing the procedure for regulating the prices of medicines.
Regulation Of The Pharmaceutical
Industry In Uzbekistan
Currently, the pharmaceutical industry in Uzbekistan is experiencing a modification of regulatory requirements. In recent years, the country has achieved positive results in the formation and development of the primary health care system for population.
Guidelines for the selection of
trade names of medicines and for
manufacturing of finished dosage
forms in the Eurasian Economic
Union
The Board of the Eurasian Economic Commission (EEC) approved on 29 January 2019 the Recommendations on the Guidelines for the Selection of Trade Names of Medicinal Products and the Guidelines for Manufacturing of Finished Dosage Forms of Medicinal Products in order to eliminate differences in the requirements for the manufacturing of finished dosage forms of medicines in Eurasian Member States Economic Union (EAEU).
Changes in the regulation of
medicines circulation in Russia in
2019
This review highlights some significant changes in federal laws and other regulatory legal acts in Russia that regulate the circulation of medicines.
Changes in the procedure for
admission of foreign medical
devices and medicines to public
procurement in Russia
On 1 January 2019, amendments to the Resolution of the Government of the Russian Federation No. 102 of 05.02.2015 that provides for restrictions and conditions for the admission of certain types of medical devices originating from foreign countries for the purpose of procurement for state and municipal needs ("Resolution No. 102")[1] and the Resolution of the Government of the Russian Federation dated November 30, 2015 No. 1289 that establishes the restrictions and conditions for admission for the purposes of procurement to ensure the state and municipal needs of medicinal products originating from foreign countries included in the list of vital and essential drugs (VED) ("Resolution No. 1289")[2], came into force.
Registration of Medical Devices in Russia: Recent Changes
The Government of the Russian Federation by its Resolution No. 633, dated 31 May 2018 introduced changes to the Rules for the State Registration of Medical Devices approved by Resolution of the Government No. 1416, dated 27 December 2012 (hereinafter - the 'Registration Rules').
Common market of medicines in
the Eurasian Economic Union:
clinical trials
On 17 July 2018, the Board of the Eurasian Economic Commission (EEС) adopted the following acts aimed at regulation of the general market of medicines in the Eurasian Economic Union (EAEU)